Use-dependent block of the pacemaker current I(f) in rabbit sinoatrial node cells by zatebradine (UL-FS 49). On the mode of action of sinus node inhibitors.
- 1 November 1993
- journal article
- abstracts
- Published by Wolters Kluwer Health in Circulation
- Vol. 88 (5) , 2389-2401
- https://doi.org/10.1161/01.cir.88.5.2389
Abstract
BACKGROUND Zatebradine (UL-FS 49) is a drug with a specific bradycardiac electrophysiological profile. It reduces heart rate by lengthening the duration of diastolic depolarization in the sinoatrial (SA) node. The ionic basis of this action, however, is not clarified. METHODS AND RESULTS We used the whole-cell patch-clamp technique to study the effects of zatebradine on ionic currents underlying diastolic depolarization of isolated rabbit SA node cells. Low concentrations of zatebradine simultaneously reduced diastolic depolarization rate and the pacemaker current I(f). The drug blocked the pacemaker current, I(f), in a use-dependent manner without causing a shift of its activation curve. At hyperpolarized potentials, unblock of I(f) occurred. Clinically relevant concentrations of the drug have little effect on the L-type calcium current or delayed rectifier potassium current. CONCLUSIONS This use-dependent block of the If channel can account for most of the pharmacological characteristics of zatebradine and is probably the mechanism of heart rate reduction caused by this agent. Thus, the sinus node inhibitor zatebradine belongs to a new class of "I(f) blockers" with possible advantages over currently available drugs for the treatment of ischemic heart disease.Keywords
This publication has 47 references indexed in Scilit:
- Ionic Current Mechanisms Generating Vertebrate Primary Cardiac Pacemaker Activity at the Single Cell Level: An Integrative ViewAnnual Review of Physiology, 1992
- Blockade of cardiac sodium channels. Competition between the permeant ion and antiarrhythmic drugs.Journal of Clinical Investigation, 1992
- A hyperpolarization-activated inward current in human myocardial cellsJournal of Molecular and Cellular Cardiology, 1992
- A593 THE HEMODYNAMIC INTERACTION OF EPINEPHRINE WITH THE SPECIFIC BRADYCARDIC AGENT UL-FS 49Anesthesiology, 1990
- Falipamil (AQ‐A 39) and UL‐FS 49Cardiovascular Drug Reviews, 1988
- Specific Bradycardic Agents, A New Therapeutic Modality for AnesthesiologyAnesthesiology, 1987
- Effects of the bradycardic agent UL-FS 49 on exercise-induced regional contractile dysfunction in dogsInternational Journal of Cardiology, 1987
- Theoretical characterization of ion channel blockade: Ligand binding to periodically accessible receptorsJournal of Theoretical Biology, 1986
- The cardiac hyperpolarizing-activated current, if. origins and developmentsProgress in Biophysics and Molecular Biology, 1985
- Antiarrhythmic Agents: The Modulated Receptor Mechanism of Action of Sodium and Calcium Channel-Blocking DrugsAnnual Review of Pharmacology and Toxicology, 1984